Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis

BACKGROUND: The impact of different anti-virus regimens on prognosis of Chronic hepatitis B (CHB) related cirrhosis remains to be explored. We aim to investigate whether CHB-related HCC patients receiving nucleoside analogue regimen or not have a different prognosis. METHODS: Two hundred forty-two C...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Infect Agent Cancer
Prif Awduron: Zhang, Ping, Liu, Qingli, Yuan, Mei, Wang, Lina
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2018
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6114711/
https://ncbi.nlm.nih.gov/pubmed/30181772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13027-018-0203-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg